1. A-Elbasit IE, Elbashir MI, Khalil IF, Alifrangis M, Giha HA (2006) The efficacy of sulfadoxine-pyrimethamine alone and in combination with chloroquine for malaria treatment in rural Eastern Sudan: the interrelation between resistance, age and gametocytogenesis. Tropical Med Int Health 11:604–612
2. Alker AP, Kazadi WM, Kutelemeni AK, Bloland PB, Tshefu AK, Meshnick SR (2008) dhfr and dhps genotype and sulfadoxine-pyrimethamine treatment failure in children with falciparum malaria in the Democratic Republic of Congo. Tropical Med Int Health 13:1384–1391
3. Al-Nihmi FM, Kolli SK, Reddy SR, Mastan BS, Togiri J, Maruthi M, Gupta R, Sijwali PS, Mishra S, Kumar KA (2017) A novel and conserved Plasmodium sporozoite membrane protein SPELD is required for maturation of exo-erythrocytic forms. Sci Rep 7:40407
4. Anas M, Sharma R, Dhamodharan V, Pradeepkumar PI, Manhas A, Srivastava K, Ahmed S, Kumar N (2017) Investigating pharmacological targeting of G-quadruplexes in the human malaria parasite. Biochemistry 56:6691–6699
5. Asthana OP, Srivastava JS, Kamboj VP, Valecha N, Sharma VP, Gupta S, Pande TK, Vishwanathan KA, Mahapatra KM, Nayak NC et al (2001) A multicentric study with arteether in patients of uncomplicated falciparum malaria. J Assoc Physicians India 49:692–696